an ultra low-dose Lo Loestrin Fe and Beyaz with added FOLATE

December 2010

You'll see two novel oral contraceptives....

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter membership benefits include:

12 issues every year — what you need to know and do, right now
Quick, practical reference charts and tools
Comprehensive CE library to meet license renewal and state requirements
Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
Plus much more!

Choose the right tier for your needs today.

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Table of Contents

You'll hear more patients ask for OxyContin "OC" instead of "OP"
Chronic Pain Cymbalta (duloxetine) for chronic musculoskeletal pain due to low back pain and osteoarthritis
Diabetes More diabetes patients are using insulin pumps
Gastroenterology LESS use of triple therapy to eradicate H. pylori
Homeopathy The recall of Hyland's Teething Tablets is raising questions about the safety of homeopathic products
Women's Health whether postmenopausal estrogen plus progestin therapy increases breast cancer risk
Women's Health an ultra low-dose Lo Loestrin Fe and Beyaz with added FOLATE
Substance Use Disorder Vivitrol (naltrexone) will be used more to prevent opioid abuse
Vaccines which influenza vaccine to use in certain high-risk patients
Cardiology whether hypertension should be treated more aggressively in African Americans than other races
Psychiatry Meds cause about 10% of cases of Parkinson-like motor symptoms
Counseling improving patient communication